Leap Therapeutics, Inc. (LPTX): Price and Financial Metrics

LPTX POWR Grades

• Growth is the dimension where LPTX ranks best; there it ranks ahead of 65.46% of US stocks.
• LPTX's strongest trending metric is Value; it's been moving down over the last 179 days.
• LPTX ranks lowest in Momentum; there it ranks in the 4th percentile.

LPTX Stock Summary

• For LPTX, its debt to operating expenses ratio is greater than that reported by merely 4.75% of US equities we're observing.
• With a price/sales ratio of 105.98, Leap Therapeutics Inc has a higher such ratio than 97.7% of stocks in our set.
• With a year-over-year growth in debt of -74.31%, Leap Therapeutics Inc's debt growth rate surpasses only 3.69% of about US stocks.
• If you're looking for stocks that are quantitatively similar to Leap Therapeutics Inc, a group of peers worth examining would be CTMX, TMDI, SQZ, GLYC, and EIGR.
• LPTX's SEC filings can be seen here. And to visit Leap Therapeutics Inc's official web site, go to www.leaptx.com.

LPTX Valuation Summary

• In comparison to the median Healthcare stock, LPTX's price/sales ratio is 1700% higher, now standing at 68.4.
• LPTX's EV/EBIT ratio has moved up 0.5 over the prior 56 months.
• LPTX's price/earnings ratio has moved up 0.3 over the prior 56 months.

Below are key valuation metrics over time for LPTX.

LPTX Growth Metrics

Its 2 year cash and equivalents growth rate is now at -24.98%.
• The 5 year net cashflow from operations growth rate now stands at 5.43%.
• The 5 year cash and equivalents growth rate now stands at 3246.66%.

LPTX's revenue has moved up $1,500,000 over the prior 61 months.

The table below shows LPTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1.5	-35.157	-40.587
2021-09-30	1.5	-30.429	-36.509
2021-06-30	1.5	-28.919	-32.427
2021-03-31	1.5	-30.618	-29.417
2020-12-31	1.5	-25.957	-37.588
2020-09-30	1.125	-25.863	-38.874

LPTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LPTX has a Quality Grade of D, ranking ahead of 18.21% of graded US stocks.
• LPTX's asset turnover comes in at 0.03 -- ranking 351st of 682 Pharmaceutical Products stocks.
• LNTH, ADMP, and CASI are the stocks whose asset turnover ratios are most correlated with LPTX.

The table below shows LPTX's key quality metrics over time.